Merit Medical Systems, Inc’s filing revealed that its Director FRED LAMPROPOULOS acquired Company’s shares for reported $0.88 million on Nov 25 ’25. In the deal valued at $88.04 per share,10,000 shares were bought.
Then, Lampropoulos Fred P. sold 25,000 shares, generating $2,182,750 in total proceeds. Upon selling the shares at $87.31, the Executive Chairman now owns 1,029,955 shares.
Before that, FRED LAMPROPOULOS bought 25,000 shares. Merit Medical Systems, Inc shares valued at $2,182,631 were divested by the Director at a price of $87.31 per share.
JP Morgan initiated its Merit Medical Systems, Inc [MMSI] rating to an Overweight in a research note published on March 28, 2025; the price target was $120. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in mid December from “an Equal weight” to “an Overweight”. Robert W. Baird began covering MMSI with “an Outperform” recommendation on June 28, 2024. CL King started covering the stock on April 11, 2024. It rated MMSI as “a Buy”.
Price Performance Review of MMSI
On Tuesday, Merit Medical Systems, Inc [NASDAQ:MMSI] saw its stock jump 0.49% to $87.6. Over the last five days, the stock has gained 4.08%. Merit Medical Systems, Inc shares have fallen nearly -16.60% since the year began. Nevertheless, the stocks have fallen -9.43% over the past one year. While a 52-week high of $111.45 was reached on 01/31/25, a 52-week low of $78.12 was recorded on 10/10/25.
Levels Of Support And Resistance For MMSI Stock
The 24-hour chart illustrates a support level at 87.00, which if violated will result in even more drops to 86.41. On the upside, there is a resistance level at 88.38. A further resistance level may holdings at 89.17.
How much short interest is there in Merit Medical Systems, Inc?
A steep rise in short interest was recorded in Merit Medical Systems, Inc stocks on 2025-11-14, dropping by -0.41 million shares to a total of 2.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 3.33 million shares. There was a decline of -14.13%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 07, 2024 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $87 price target.
